{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:12:20Z","timestamp":1793383940946,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971651"],"award-info":[{"award-number":["81971651"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Natural Science Foundation of Fujian","award":["2019J01454"],"award-info":[{"award-number":["2019J01454"]}]},{"name":"Fujian Provincial Health Commmission Science and Technology Programme","award":["2021QNA031"],"award-info":[{"award-number":["2021QNA031"]}]},{"name":"Sailing Fund of Fujian Medical University","award":["2020QH1044"],"award-info":[{"award-number":["2020QH1044"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s00259-022-05799-5","type":"journal-article","created":{"date-parts":[[2022,4,24]],"date-time":"2022-04-24T23:30:35Z","timestamp":1650843035000},"page":"2960-2971","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["[68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of gastric cancer: comparison with [18F]FDG PET\/CT"],"prefix":"10.1007","volume":"49","author":[{"given":"Rong","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zefang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-4953","authenticated-orcid":false,"given":"Weibing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"5799_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396:635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5.","journal-title":"Lancet"},{"key":"5799_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/ctrv.2000.0164","volume":"26","author":"DH Roukos","year":"2000","unstructured":"Roukos DH. Current status and future perspectives in gastric cancer management. Cancer Treat Rev. 2000;26:243\u201355. https:\/\/doi.org\/10.1053\/ctrv.2000.0164.","journal-title":"Cancer Treat Rev"},{"key":"5799_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/rg.261055078","volume":"26","author":"JS Lim","year":"2006","unstructured":"Lim JS, Yun MJ, Kim MJ, Hyung WJ, Park MS, Choi JY, et al. CT and PET in stomach cancer: preoperative staging and monitoring of response to therapy. Radiographics. 2006;26:143\u201356. https:\/\/doi.org\/10.1148\/rg.261055078.","journal-title":"Radiographics"},{"key":"5799_CR4","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1002\/cncr.27550","volume":"118","author":"E Smyth","year":"2012","unstructured":"Smyth E, Sch\u00f6der H, Strong VE, Capanu M, Kelsen DP, Coit DG, et al. A prospective evaluation of the utility of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer. Cancer. 2012;118:5481\u20138. https:\/\/doi.org\/10.1002\/cncr.27550.","journal-title":"Cancer"},{"key":"5799_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.18999\/nagjms.79.4.527","volume":"79","author":"K Kitajima","year":"2017","unstructured":"Kitajima K, Nakajo M, Kaida H, Minamimoto R, Hirata K, Tsurusaki M, et al. Present and future roles of FDG-PET\/CT imaging in the management of gastrointestinal cancer: an update. Nagoya J Med Sci. 2017;79:527\u201343. https:\/\/doi.org\/10.18999\/nagjms.79.4.527.","journal-title":"Nagoya J Med Sci"},{"key":"5799_CR6","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1007\/s00259-020-05146-6","volume":"48","author":"L Zhao","year":"2021","unstructured":"Zhao L, Pang Y, Luo Z, Fu K, Yang T, Zhao L, et al. Role of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in the evaluation of peritoneal carcinomatosis and comparison with [18F]-FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2021;48:1944\u201355. https:\/\/doi.org\/10.1007\/s00259-020-05146-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR7","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","volume":"87","author":"P Garin-Chesa","year":"1990","unstructured":"Garin-Chesa P, Old LJ, Rettig WJ. Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. Proc Natl Acad Sci U S A. 1990;87:7235\u20139. https:\/\/doi.org\/10.1073\/pnas.87.18.7235.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5799_CR8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/prca.201300095","volume":"8","author":"EJ Hamson","year":"2014","unstructured":"Hamson EJ, Keane FM, Tholen S, Schilling O, Gorrell MD. Understanding fibroblast activation protein (FAP): substrates, activities, expression and targeting for cancer therapy. Proteomics Clin Appl. 2014;8:454\u201363. https:\/\/doi.org\/10.1002\/prca.201300095.","journal-title":"Proteomics Clin Appl"},{"key":"5799_CR9","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ijc.2910580314","volume":"58","author":"WJ Rettig","year":"1994","unstructured":"Rettig WJ, Su SL, Fortunato SR, Scanlan MJ, Raj BK, Garin-Chesa P, et al. Fibroblast activation protein: purification, epitope mapping and induction by growth factors. Int J Cancer. 1994;58:385\u201392. https:\/\/doi.org\/10.1002\/ijc.2910580314.","journal-title":"Int J Cancer"},{"key":"5799_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/MPA.0b013e31816618ce","volume":"37","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Alpaugh RK, Palazzo I, Meropol NJ, Rogatko A, Xu Z, et al. Fibroblast activation protein and its relationship to clinical outcome in pancreatic adenocarcinoma. Pancreas. 2008;37:154\u20138. https:\/\/doi.org\/10.1097\/MPA.0b013e31816618ce.","journal-title":"Pancreas"},{"key":"5799_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.canlet.2011.01.011","volume":"303","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Tang H, Cai J, Zhang T, Guo J, Feng D, et al. Ovarian cancer-associated fibroblasts contribute to epithelial ovarian carcinoma metastasis by promoting angiogenesis, lymphangiogenesis and tumor cell invasion. Cancer Lett. 2011;303:47\u201355. https:\/\/doi.org\/10.1016\/j.canlet.2011.01.011.","journal-title":"Cancer Lett"},{"key":"5799_CR12","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1309\/ajcp86ppbngohnnl","volume":"131","author":"MJ Ju","year":"2009","unstructured":"Ju MJ, Qiu SJ, Fan J, Xiao YS, Gao Q, Zhou J, et al. Peritumoral activated hepatic stellate cells predict poor clinical outcome in hepatocellular carcinoma after curative resection. Am J Clin Pathol. 2009;131:498\u2013510. https:\/\/doi.org\/10.1309\/ajcp86ppbngohnnl.","journal-title":"Am J Clin Pathol"},{"key":"5799_CR13","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s13277-012-0638-2","volume":"34","author":"ML Wikberg","year":"2013","unstructured":"Wikberg ML, Edin S, Lundberg IV, Van Guelpen B, Dahlin AM, Ruteg\u00e5rd J, et al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis. Tumour Biol. 2013;34:1013\u201320. https:\/\/doi.org\/10.1007\/s13277-012-0638-2.","journal-title":"Tumour Biol"},{"key":"5799_CR14","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.2967\/jnumed.118.210435","volume":"59","author":"A Loktev","year":"2018","unstructured":"Loktev A, Lindner T, Mier W, Debus J, Altmann A, J\u00e4ger D, et al. A tumor-imaging method targeting cancer-associated fibroblasts. J Nucl Med. 2018;59:1423\u20139. https:\/\/doi.org\/10.2967\/jnumed.118.210435.","journal-title":"J Nucl Med"},{"key":"5799_CR15","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging. 2020;47:1820\u201332. https:\/\/doi.org\/10.1007\/s00259-020-04769-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR16","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med. 2019;60:801\u20135. https:\/\/doi.org\/10.2967\/jnumed.119.227967.","journal-title":"J Nucl Med"},{"key":"5799_CR17","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","volume":"37","author":"E Pur\u00e9","year":"2018","unstructured":"Pur\u00e9 E, Blomberg R. Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics. Oncogene. 2018;37:4343\u201357. https:\/\/doi.org\/10.1038\/s41388-018-0275-3.","journal-title":"Oncogene"},{"key":"5799_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2967\/jnumed.120.258467","volume":"63","author":"C Qin","year":"2022","unstructured":"Qin C, Shao F, Gai Y, Liu Q, Ruan W, Liu F, et al. 68Ga-DOTA-FAPI-04 PET\/MR in the evaluation of gastric carcinomas: comparison with 18F-FDG PET\/CT. J Nucl Med. 2022;63:81\u20138. https:\/\/doi.org\/10.2967\/jnumed.120.258467.","journal-title":"J Nucl Med"},{"key":"5799_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge SB, Greene FL, et al. AJCC cancer staging manual. 8th ed. New York, NY: Springer; 2017.","edition":"8"},{"key":"5799_CR20","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00259-020-04940-6","volume":"48","author":"H Chen","year":"2021","unstructured":"Chen H, Zhao L, Ruan D, Pang Y, Hao B, Dai Y, et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET\/CT in patients presenting with inconclusive [18F]FDG PET\/CT findings. Eur J Nucl Med Mol Imaging. 2021;48:73\u201386. https:\/\/doi.org\/10.1007\/s00259-020-04940-6.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR21","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s00259-020-04882-z","volume":"48","author":"X Shi","year":"2021","unstructured":"Shi X, Xing H, Yang X, Li F, Yao S, Zhang H, et al. Fibroblast imaging of hepatic carcinoma with 68Ga-FAPI-04 PET\/CT: a pilot study in patients with suspected hepatic nodules. Eur J Nucl Med Mol Imaging. 2021;48:196\u2013203. https:\/\/doi.org\/10.1007\/s00259-020-04882-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.2967\/jnumed.119.237016","volume":"61","author":"SA Koerber","year":"2020","unstructured":"Koerber SA, Staudinger F, Kratochwil C, Adeberg S, Haefner MF, Ungerechts G, et al. The role of 68Ga-FAPI PET\/CT for patients with malignancies of the lower gastrointestinal tract: first clinical experience. J Nucl Med. 2020;61:1331\u20136. https:\/\/doi.org\/10.2967\/jnumed.119.237016.","journal-title":"J Nucl Med"},{"key":"5799_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00268-003-7191-5","volume":"28","author":"E Mochiki","year":"2004","unstructured":"Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of 18F\u20132-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg. 2004;28:247\u201353. https:\/\/doi.org\/10.1007\/s00268-003-7191-5.","journal-title":"World J Surg"},{"key":"5799_CR24","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s00259-001-0743-8","volume":"29","author":"T De Potter","year":"2002","unstructured":"De Potter T, Flamen P, Van Cutsem E, Penninckx F, Filez L, Bormans G, et al. Whole-body PET with FDG for the diagnosis of recurrent gastric cancer. Eur J Nucl Med Mol Imaging. 2002;29:525\u20139. https:\/\/doi.org\/10.1007\/s00259-001-0743-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1007\/s00259-002-1029-5","volume":"30","author":"A Stahl","year":"2003","unstructured":"Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging. 2003;30:288\u201395. https:\/\/doi.org\/10.1007\/s00259-002-1029-5.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR26","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1097-0142(20010801)92:3<634::aid-cncr1364>3.0.co;2-x","volume":"92","author":"T Kawamura","year":"2001","unstructured":"Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer. 2001;92:634\u201341. https:\/\/doi.org\/10.1002\/1097-0142(20010801)92:3%3c634::aid-cncr1364%3e3.0.co;2-x.","journal-title":"Cancer"},{"key":"5799_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4274\/mirt.26349","volume":"24","author":"M Filik","year":"2015","unstructured":"Filik M, Kir KM, Aksel B, Soyda \u00c7, \u00d6zkan E, K\u00fc\u00e7\u00fck \u00d6N, et al. The role of 18F-FDG PET\/CT in the primary staging of gastric cancer. Mol Imaging Radionucl Ther. 2015;24:15\u201320. https:\/\/doi.org\/10.4274\/mirt.26349.","journal-title":"Mol Imaging Radionucl Ther"},{"key":"5799_CR28","doi-asserted-by":"publisher","unstructured":"Jiang D, Chen X, You Z, Wang H, Xie F. Comparison of 68Ga-FAPI-04 and 18F-FDG for the detection of primary gastric cancers and metastasis. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-326617\/v1.","DOI":"10.21203\/rs.3.rs-326617\/v1"},{"key":"5799_CR29","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1097\/MNM.0b013e328357b2d9","volume":"33","author":"YY Lu","year":"2012","unstructured":"Lu YY, Chen JH, Ding HJ, Chien CR, Lin WY, Kao CH. A systematic review and meta-analysis of pretherapeutic lymph node staging of colorectal cancer by 18F-FDG PET or PET\/CT. Nucl Med Commun. 2012;33:1127\u201333. https:\/\/doi.org\/10.1097\/MNM.0b013e328357b2d9.","journal-title":"Nucl Med Commun"},{"key":"5799_CR30","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/jso.21224","volume":"99","author":"NG Coburn","year":"2009","unstructured":"Coburn NG. Lymph nodes and gastric cancer. J Surg Oncol. 2009;99:199\u2013206. https:\/\/doi.org\/10.1002\/jso.21224.","journal-title":"J Surg Oncol"},{"key":"5799_CR31","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/jso.21985","volume":"104","author":"HH Oh","year":"2011","unstructured":"Oh HH, Lee SE, Choi IS, Choi WJ, Yoon DS, Min HS, et al. The peak-standardized uptake value (P-SUV) by preoperative positron emission tomography-computed tomography (PET-CT) is a useful indicator of lymph node metastasis in gastric cancer. J Surg Oncol. 2011;104:530\u20133. https:\/\/doi.org\/10.1002\/jso.21985.","journal-title":"J Surg Oncol"},{"key":"5799_CR32","first-page":"782","volume":"55","author":"QM Yang","year":"2008","unstructured":"Yang QM, Kawamura T, Itoh H, Bando E, Nemoto M, Akamoto S, et al. Is PET-CT suitable for predicting lymph node status for gastric cancer? Hepatogastroenterology. 2008;55:782\u20135.","journal-title":"Hepatogastroenterology"},{"key":"5799_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1148\/radiol.2020203275","volume":"298","author":"Y Pang","year":"2021","unstructured":"Pang Y, Zhao L, Luo Z, Hao B, Wu H, Lin Q, et al. Comparison of 68Ga-FAPI and 18F-FDG uptake in gastric, duodenal, and colorectal cancers. Radiology. 2021;298:393\u2013402. https:\/\/doi.org\/10.1148\/radiol.2020203275.","journal-title":"Radiology"},{"key":"5799_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05494-x","author":"J Kuten","year":"2021","unstructured":"Kuten J, Levine C, Shamni O, Pelles S, Wolf I, Lahat G, et al. Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET\/CT in evaluating the extent of disease in gastric adenocarcinoma. Eur J Nucl Med Mol Imaging. 2021. https:\/\/doi.org\/10.1007\/s00259-021-05494-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5799_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.4942","volume":"243","author":"A Capobianco","year":"2017","unstructured":"Capobianco A, Cottone L, Monno A, Manfredi AA, Rovere-Querini P. The peritoneum: healing, immunity, and diseases. J Pathol. 2017;243:137\u201347. https:\/\/doi.org\/10.1002\/path.4942.","journal-title":"J Pathol"},{"key":"5799_CR36","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3892\/ijmm.2011.852","volume":"29","author":"ZD Lv","year":"2012","unstructured":"Lv ZD, Wang HB, Li FN, Wu L, Liu C, Nie G, et al. TGF-\u03b21 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis. Int J Mol Med. 2012;29:373\u20139. https:\/\/doi.org\/10.3892\/ijmm.2011.852.","journal-title":"Int J Mol Med"},{"key":"5799_CR37","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.2174\/156652412803833607","volume":"12","author":"M Jacob","year":"2012","unstructured":"Jacob M, Chang L, Pur\u00e9 E. Fibroblast activation protein in remodeling tissues. Curr Mol Med. 2012;12:1220\u201343. https:\/\/doi.org\/10.2174\/156652412803833607.","journal-title":"Curr Mol Med"},{"key":"5799_CR38","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.3892\/mmr.2015.3197","volume":"11","author":"F Zi","year":"2015","unstructured":"Zi F, He J, He D, Li Y, Yang L, Cai Z. Fibroblast activation protein \u03b1 in tumor microenvironment: recent progression and implications (review). Mol Med Rep. 2015;11:3203\u201311. https:\/\/doi.org\/10.3892\/mmr.2015.3197.","journal-title":"Mol Med Rep"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-022-05799-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-022-05799-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T01:13:52Z","timestamp":1655514832000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-022-05799-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["5799"],"URL":"https:\/\/doi.org\/10.1007\/s00259-022-05799-5","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"assertion":[{"value":"5 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human participants were carried out in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any experiments with animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}